Recent Cancer Treatment Linked to Worse COVID-19 Outcomes
A history of cancer more than 1 year before COVID-19 diagnosis not tied to increased mortality or hospitalization.
A history of cancer more than 1 year before COVID-19 diagnosis not tied to increased mortality or hospitalization.
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Sufficient circulating vitamin D concentration linked to lower risk for breast cancer in Hispanic/Latina women.
However, there were no statistically significant changes in rates by race.
However, higher risk seen for breakthrough infections and severe outcomes, especially for hematologic malignancies.
Clinicians should continue to counsel patients that false-positive results are an expected outcome of screening mammography. Age and breast density should be factored in when deciding the frequency of screening for average-risk women.
March 2022 FDA approvals include treatments for Alzheimer disease, endometrial carcinoma, metastatic melanoma, and a genetic seizure disorder.
Role of cumulative lifetime excess weight greater than role of excess BMI measured at a single time point.